Clinical trial Recruiting at 1 site Interventional Ages 4 to 8

Intranasal Midazolam Plus Nitrous Oxide for Anxious Kids Compared to Nitrous Oxide Alone

Official title: Comparative Evaluation of Intranasal Atomized Midazalom Combined With Nitrous Oxide Versus Nitrous Oxide Monotherapy for Behaviour Management in Anxious Pediatric Dental Patient: a Randomized Control Trial

Run by Shaheed Zulfiqar Ali Bhutto Medical University · NCT07876024 · Data updated 2026-11-12

This study tests whether adding a mist-like intranasal midazolam to nitrous oxide helps keep anxious children calm and finish dental treatment better than nitrous oxide alone.

Quick facts

Study typeInterventional
Ages4 Years to 8 Years
SexAll
Enrollment68 (estimated)
SponsorShaheed Zulfiqar Ali Bhutto Medical University
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedNovember 30, 2026
Study endsJanuary 30, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07876024 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–8 with confirmed dental anxiety (Frankl score 1–2), ASA I–II, needing short dental procedures in up to two quadrants.

Probably not a fit

Children without significant anxiety or with contraindications to midazolam/nitrous oxide may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind trial compares two sedation approaches in anxious children aged 4–8 requiring limited dental procedures. Children are assigned to receive either intranasal atomized midazolam with nitrous oxide or nitrous oxide alone, with outcomes including treatment success, mask acceptance, behavior during the procedure, recovery time, and adverse events. The study uses validated scales to measure behavior and recovery and is conducted at SZABMU in Islamabad over a three-month period after IRB approval. The mucosal atomization device is evaluated for comfort and nasal irritation, aiming to establish a predictable, non-invasive outpatient technique aligned with Green Dentistry principles.

Why it matters

Potential benefit: If successful, the approach could provide a safer, more reliable option for managing dental anxiety in children.

How similar studies have gone: Previous studies suggest potential benefits of intranasal sedatives, but this specific combination and delivery method are being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged between 4 to 8 years old.
* Dental anxiety confirmed by a baseline Frankl Behavior Rating Scale score of 1 (Definitely Negative) or 2 (Negative) during initial examination.
* Healthy pediatric patients categorized under American Society of Anesthesiologists (ASA) class I or II physical status.
* Confirmed patent nasal airway without active congestion, and verified compliance with standard ASA NPO (fasting) rules.
* Planned dental interventions requiring local anesthesia confined to a maximum of two quadrants (e.g., pulpotomies, pulpectomies, stainless steel crowns, or uncomplicated primary extractions).
* Expected operational duration spanning 20 to 30 minutes, with a definitive termination threshold at 45 minutes.
* Provision of signed, informed written consent by a parent or legal guardian.

Exclusion Criteria:

* Pathological nasal airway obstructions, severely enlarged adenoids, or active upper respiratory tract infections.
* Mouth breathers or patients with structural craniofacial anomalies impeding proper nasal hood adaptation
* Known systemic contraindications or allergies to benzodiazepines, nitrous oxide or local anesthetic agents.
* Severe tonsillar hypertrophy classified as Class 3 or Class 4 on the Brodsky Scale, introducing airway obstruction risks.
* Cognitive, developmental, or psychological delays that impair standard behavioral monitoring scales.

Where it's running

  • Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU) Islamabad
    Islamabad, Pakistan
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.